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Abstract Osteoarthritis (OA) is the most common joint
disease, characterized by matrix degradation and changes
in chondrocyte morphology and metabolism. Literature
reported that electromagnetic fields (EMFs) can produce
benefits in OA patients, even if EMFs mechanism of action
is debated. Human osteoarthritic chondrocytes isolated
from femoral heads were cultured in vitro in bidimensional
(2-D) flasks and in three-dimensional (3-D) alginate beads
to mimic closely cartilage environment in vivo. Cells were
exposed 30 min/day for 2 weeks to extremely low-fre-
quency electromagnetic field (ELF) with fixed frequency
(100 Hz) and to therapeutic application of musically
modulated electromagnetic field (TAMMEF) with variable
frequencies, intensities, and waveforms. Cell viability was
measured at days 7 and 14, while healthy-cell density,
heavily vacuolized (hv) cell density, and cluster density
were measured by light microscopy only for 3-D cultures
after treatments. Cell morphology was observed for 2-D
and 3-D cultures by transmission electron microscopy
(TEM). Chondrocyte exposure to TAMMEF enhances cell
viability at days 7 and 14 compared to ELF. Light
microscopy analysis showed that TAMMEF enhances
healthy-cell density, reduces hv-cell density and clustering,
compared to ELF. Furthermore, TEM analysis showed
different morphology for 2-D (fibroblast-like) and 3-D
(rounded shape) cultures, confirming light microscopy
results. In conclusion, EMFs are effective and safe for OA
chondrocytes. TAMMEF can positively interfere with OA
chondrocytes representing an innovative non-pharmaco-
logical approach to treat OA.
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Introduction
Osteoarthritis (OA) is one of the most frequently occurring
rheumatic diseases. It is a slowly progressive degenerative
disorder, characterized by gradual loss of articular cartilage
due to disruption of chondrocyte–matrix associations and
alterations of metabolic responses in the chondrocyte [1].
The etiology of OA is still not completely understood and
represents an open debate in the literature [2]. Pharmaco-
logic interventions have focused primarily on improving
symptoms, by the use of non-steroidal antiinflammatory
drugs (NSAIDs) and by means of new agents, the so-called
‘‘Chondroprotective’’ or ‘‘Structure-modifying’’ Agents,
which seem to counter arthritic degenerative processes and
encourage normalization of the synovial fluid and cartilage
matrix [3, 4]. Although most of these agents have shown
promising effects in vitro, none has been proven to produce
clinically meaningful structure-modifying effects in
humans with osteoarthritis [5]. Therefore, the treatment of
OA is usually unsatisfactory at present and the need to
create effective and valid alternatives to standard phar-
macological therapies rose up [6]. Some investigators
hypothesized that the stimulation of bone and cartilage
through the application of specific electric and magnetic
fields could interfere in mechanisms such us inflammation,
growth and repair [7–9]. Literature reports that bone and
cartilage can be stimulated by electromagnetic fields
(EMFs) to increase the synthesis of extracellular matrix
[10, 11]. Furthermore, extracellular matrix of the hyaline
cartilage is piezoelectric, converting electromagnetic
oscillations to mechanical vibrations and vice versa [12].
The analgesic efficacy and tolerability of a low-frequency
electromagnetic field (ELF), modulated at a frequency of
100 Hz with a sinusoidal waveform and mean induction of
a few gauss, has been demonstrated in osteoporosis [13],
rheumatoid arthritis [14] and osteoarthritis [15, 16]. The
potential effects of electromagnetic fields on human cells
are related to many factors, such as the method of cell
culture and the properties of EMFs (frequency, intensity,
waveform) [17–21]. In the present study, we introduce, in
comparison with the most traditional ELF, the new
TAMMEF system (Therapeutic Application of Musically
Modulated Electromagnetic Field), whose codes or
parameters such as frequency, intensity and waveform are
modified in time, randomly varying within the respective
ranges, so that all the possible codes can occur during a
single application (usually 30 min). Furthermore, EMFs
used for in vivo treatments are often characterized by
higher energies than EMFs used for in vitro studies because
EMFs applied in vitro directly interfere with cells without
possible interference with other tissues or organs [11–15].
For this reason, the results obtained in vitro are difficult to
compare to that obtained in vivo. The aim of the present
study is to compare the in vitro effects (in terms of cell
viability, healthy-cell density, hv-cell density and cluster-
ing density) between standard EMFs treatments and the
new TAMMEF system on human osteoarthritic chondro-
cytes cultured under standard conditions and in three-
dimensional alginate beads. We chose to analyze heavily
vacuolized cells and clustering formation because little is
known in the literature about these two phenomena. For
instance, it is reported that during OA, chondrocytes are
eliminated following two mechanisms such as apoptosis
and autophagy (by cytoplasmic vacuolization) [22, 23].
Furthermore, the term of ‘‘Chondroptosis’’ was used for the
first time to design cell death type present in OA cartilage
which combines some apoptotic and some autophagic
processes [24]. Finally, the concept of ‘‘cluster’’ represents
an open debate in the literature because the exact steps
leading to formation of these cell clusters in OA cartilage
have not been clearly identified [25].
The research protocol was approved by our local ethics
committee, and each donor provided informed written
consent.
Materials and methods
Cell cultures
Human chondrocytes were obtained from 20 OA patients
(10 males and 10 females, age 55–80 years) undergoing to
total femoral head replacement. Articular cartilage slices
isolated from the femoral heads were dissected under
aseptic conditions. Chondrocytes were isolated enzymati-
cally from 20 OA cartilage samples and pooled before the
experiments. All enzymatic solutions were made in DMEM
(Sigma-Aldrich. St. Louis, MO, USA) supplemented with
penicillin (100 U/mL) (Sigma-Aldrich. St. Louis, MO,
USA), streptomycin (100 lg/mL) (Sigma-Aldrich. St. Louis,
MO, USA), 0.25 lg/ml amphotericin B (Sigma-Aldrich.
St. Louis, MO, USA), and 10 % FBS (Sigma-Aldrich.
St. Louis, MO, USA). Articular cartilage was treated
with 0.1 % sheep testes hyaluronidase (Sigma-Aldrich.
St. Louis, MO, USA), in DMEM for 30 min at 37 C. The
hyaluronidase solution was then replaced by 0.5 % of
Streptomyces griseus Pronase E (Sigma-Aldrich. St. Louis,
MO, USA), in DMEM for 60 min at 37 C. Cartilage was
then washed twice with DMEM containing 10 % FBS and
digested with type II collagenase (1 mg/mL) (Sigma-
Aldrich. St. Louis, MO, USA), in DMEM at 37 C for
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45 min at 37 C. Cell suspension was filtered with cell
strainer 70 lm (BD Biosciences Franklin Lakes, NJ, USA),
rinsed in the medium and centrifuged at 1009g for 10 min.
Viability and number of isolated cells were estimated by
vital staining using trypan blue (Sigma-Aldrich. St. Louis,
MO, USA). Usually, 1 9 106 chondrocytes could be
obtained from 1 g of cartilage of each patient. Chondro-
cytes (about 1 9 106 cells) were cultured in DMEM sup-
plemented with 100 U/penicillin, 100 lg/mL streptomycin
2 mM glutamine, and 10 % FCS onto 75 cm2 flasks (BD
Costar Cambridge, MA, USA) for bidimensional cultures
and incubated at 37 C in a atmosphere of 5 % CO2 95 %
air, till confluence (2–3 weeks). To obtain three-dimen-
sional cultures, cell suspension (about 1 9 106 cells) was
mixed to a 1.2 % solution of sterile alginate in 0.15 M
NaCl. Then, alginate/cell suspension was extruded through
a 22-gauge needle and dropped into a 102 mM CaCl2
solution. The beads with 3 mm diameter were allowed to
polymerize for 10 min and then transferred in six-well
multiwall plates (BD Costar Cambridge, MA, USA) (5 beads
per well) with DMEM supplemented with 100 U/penicillin,
100 lg/mL streptomycin 2 mM glutamine, 10 % FCS and
25 lg/ml ascorbic acid (Sigma-Aldrich. St. Louis, MO,
USA) and incubated at 37 C in a atmosphere of 5 % CO2
95 % air.
Treatments with ELF and TAMMEF systems
To perform our experiments, two different types of EMFs
were used (Fig. 1a): (a) ELF EMFs (Extremely Low-Fre-
quency Electromagnetic Fields used as gold standard)
modulated at a standard frequency of 100 Hz with a
sinusoidal waveform and a mean induction of a few gauss;
(b) TAMMEF system (Therapeutic Application of
Musically Modulated Electromagnetic Fields), whose parame-
ters or ‘‘codes’’ (frequency, intensity and waveform) vary
in time, since they are generated by a piece of music
(Rachmaninov’s Piano Concerto number 2 in C minor,
Op.18 for piano and orchestra). We chose a 100 Hz fixed
frequency for ELF MF because in the most frequently
adopted in the literature and in our previous studies
[14, 15]. To conduct the experiments, the flasks and mul-
tiwells containing OA chondrocytes were positioned
between the magnetic poles in order to be directly within
the generated EMF (Fig. 1b). The cells of each patient
were divided into two groups: (a) 2-D cell culture; (b) 3-D
alginate beads cell culture. For each group, the cells were
splitted in three parts in order to receive the following
treatments: (1) ELF EMFs (30 min/day for 2 weeks); (2)
TAMMEF (30 min/day for 2 weeks); (3) Sham Exposed
(S.E.) cells served as the reference control. These cells were
removed from the incubator and maintained at a distance
far from the EMFs (30 min/day for 2 weeks).
Cell viability assay
Cell viability was measured during the treatment with
EMFs at days 7 and 14 using the alamarBlue assay
(Invitrogen S.R.L, MI, ITALY). The culture medium was
removed and replaced with 10 % (v/v) alamarBlue in
DMEM without FBS and incubated for 4 h (37 C, 5 %
CO2). The system incorporates the fluorometric/colori-
metric REDOX indicator which changes from oxidized
form (non-fluorescent, blue) to reduced form (fluorescent,
red). The changing of the color, from initial blue to final
red, is directly proportional to the amount of the reagent
reduced and provides an estimation of the number of viable
cells submitted to the test. Fluorescence intensity was read
using a Multiskan EX microplate spectrofluorometer
200–240 V (Thermo Fisher Scientific, 81 Waltham MA
02454 USA) at excitation 530 nm and emission 590 nm.
Fig. 1 The apparatus used to generate the ELF EMF and TAMMEF.
a To conduct an experiment, cell samples were positioned between
the polar expansions in order to be directly in the generated EMF.
b Sham Exposed cells were maintained at a distance far from the
EMF; thus, it served as a control. The experiments were carried out at
room temperature at time (30 min) for 2 weeks
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Light and electron microscopy
After trypsinization (only for 2-D cell culture), 2-D and
3-D alginate beads cells were fixed at 4 C in Karnovsky
0.1 M solution, 2.5 % glutaraldehyde and 4 % formalde-
hyde, at pH 7.4, then washed twice in cacodylate buffer
0.1 M, pH 7.4 and post-fixed for 2 hours in 1 % osmium
tetroxide at 4 C. After four washes in cacodylate buffer,
cells were dehydrated in ethanol gradient, transferred into
propylene oxide, included into araldite resin and poly-
merized at 60 C for 24 h. Semithin sections were colored
with toluidine blue and observed at Axioscope (Zeiss Jena
GmbH, Germany) microscope. Ultrathin sections were
contrasted with uranyl acetate and lead citrate and were
observed at Philips TEM CM-10 (Huntsville, Alabama,
USA) transmission electron microscopy.
Alginate beads cell cultures light microscopy analysis
Three-dimensional cell-alginate beads treated with ELF,
TAMMEF and S.E. were fixed as previously described
after 14 days of treatments and cut into semithin sections.
For each alginate bead, 9 semithin sections, distanced
20 lm, were obtained. In each section, healthy-cell
(no autophagic vesicles, no apoptotic blebbing) density,
heavily vacuolized (hv) cell density and cluster density
were evaluated with AxioVision 4.6 software (Carl Zeiss
MicroImaging GmbH, Go¨ttingen, Germany). For this
study, cells were classified as hv-cells when vacuoles
occupied more than 50 % of their cytoplasmic space. Data
statistical analysis was performed with GraphPad Prism 5.0
software (1992–2007 GraphPad Software, Inc).
Statistical analysis
Statistical analysis was performed using GraphPad Prism
5 for Windows. To analyze different protein expressions,
one-way ANOVA and Newman–Keuls Multiple Compar-
ison Test were performed. For cell viability statistics, data
Fig. 2 2D and 3D cell viability
recorded after 7 and 14 days of
treatments
Fig. 3 Healthy-cell density, heavily vacuolized (hv) cell density and
clusters density calculated as the mean of 9 semithin sections with
axial distance of 20 lm for each alginate bead for S.E., ELF and
TAMMEF cells after 14 days of treatments
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are reported as the percentage increment compared to
control (100 %). For light microscopy statistics, densities
were calculated as the mean of 9 semithin sections with
axial distance of 20 lm for each alginate bead. Data are
reported as the means ± standard deviations.
Results
Cell viability
Figure 2 shows cell viability at days 7 and 14 for both 2-D
and 3-D cultures. Six independent samples for each culture
condition and for each treatment were analyzed to perform
statistical calculations. For 2-D cell culture, there is no
statistically relevant change in cell viability between ELF,
TAMMEF and S.E. after 7 days of treatments. But, after
14 days of treatments, there is a statistically relevant
decrease in cell viability of ELF-treated cells compared to
TAMMEF (Anova, p = 0.04) and S.E. (Anova, p = 0.03),
while there are no statistically relevant changes in cell
viability between TAMMEF and S.E. (Anova, p = 0.20).
For 3-D cell culture, there is no statistically relevant
change in cell viability after 7 days of treatments between
ELF, TAMMEF and S.E., while after 14 days of treatment,
there is a statistically relevant decrease in cell viability
of ELF-treated cells compared to TAMMEF (Anova,
p = 0.003) and S.E. (Anova, p = 0.003). No relevant
differences were found between TAMMEF and S.E.
(Anova, p = 0.16).
Alginate beads cell cultures light microscopy analysis
Figure 3 shows healthy-cell density, hv-cell density and
clustering density. Healthy-cell mean density was lower in
ELF-treated cells respect to S.E. (p \ 0.05), and TAMMEF
(p \ 0.05). Moreover, the hv-cell mean density was lower
in TAMMEF-treated cells compared to S.E. (p \ 0.0001)
and ELF (p \ 0.0001). Finally, the clustering mean density
was lower in TAMMEF-treated cells compared to S.E.
(p \ 0.001) and ELF (p \ 0.001). Clusters were also
observed (Fig. 4).
Electron microscopy
Figure 5 shows transmission electron microscopic analysis
of cells cultured in 2-D and 3-D substrates. Chondrocytes
cultured in 2-D flasks showed a fibroblast-like elongated
phenotype. On the contrary, chondrocytes cultured in 3-D
alginate beads showed the typical chondrocyte phenotype
consisting in rounded shape chondrocytes. Cells showed
features of anabolic activity, such as euchromatic nuclei,
abundant RER and Golgi profiles, many transport vesicles,
as well as secreted extracellular matrix. Furthermore, both
2-D and 3-D cells treated with ELF system showed more
vacuoles and apoptotic bodies in the cytoplasm compared
to 2-D and 3-D cells treated with TAMMEF and 2-D
(Fig. 3a) and 3-D (Fig. 3b) S.E. cells. Clusters were also
observed (Fig. 6).
Discussion
In our opinion, this study documents first of all that EMFs
could positively interfere with OA chondrocytes in cul-
tures. In particular, the results obtained with TAMMEF
system showed that EMfs do not affect cell viability, do not
induce uncontrolled proliferation and are not dangerous for
in vitro studies [26–29]. Differences in the growth rate
between treated and untreated chondrocyte cultures can be
explained as a possible interference that electromagnetic
fields may have on the state of cells’ electric charge, in
terms of the ability of chondrocytes to restore the correct
intracellular energetic equilibrium [30]. Moreover, the
Fig. 4 Clusters of varying morphology (light microscopy, scale bar
10 lm) following Ross’ classification. In type 1 clusters, one layered
chondrocytes in an oval conformation surrounds a central area filled
with amorphous material. Type 2 clusters suggest a more advanced
process, with concentric cell layers (asterisk) surrounding the cavity
in a spiral fashion. In type 3 clusters, flattened cells surround an area
containing a viable cell. Type 4 cluster composed of tightly packed
cells, with indistinct cell boundaries
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Fig. 5 2D and 3D cultures of Sham Exposed, ELF and TAMMEF
14-day-treated chondrocytes. 2D S.E. cells show a typical, elongated
fibroblast-like morphology, some vacuoles with autophagic features
(arrow) are observed (original magnification 93,900). 3D S.E.
chondrocytes in alginate beads showed typical rounded chondrocyte
morphology, mitochondria (M) and dilated transport vesicles con-
taining floccular material, likely directed to extracellular matrix
(single asterisk). Occasional lipid vacuoles (double asterisk) and
autophagic vacuoles are also observed. 2D ELF. Fibroblast-like
elongated morphology of chondrocytes showed features of chondrop-
tosis, with indented nucleus and autophagic vesicles. A large
autophagic vacuole (single asterisk), containing cell debris and
partially membrane limited (double asterisk), is observed, as well as
extrusion of vesicles in the extracellular environment (arrow). 3D
ELF cells exhibited early chondroptosis. Cytoplasm is almost filled
with large vacuoles and apoptotic bodies showing myelin-like
membranes (arrow), indicative of autophagy, near apoptotic bodies
(o.m. 98900). 2D TAMMEF cells showed cytoskeletal assembly
with fibroblast-like F-actin thick fibers, or stress fiber (single
asterisk). Abundant RER and Golgi profiles are observed in
cytoplasm (arrow) (o.m. 98,900). 3D TAMMEF cells exhibited
typical chondrocyte morphology, with abundant mitochondria
(M) and transport vesicles (o.m. 98,900)
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molecular mechanisms through which low-frequency
electromagnetic fields could interfere with chondrocyte
proliferation and differentiation have been partially clari-
fied [31]. To evaluate the best efficacy of EMFs on cell
culture conditions must mimic closely the in vivo envi-
ronment of the cell type [32]. Hence, the need to cultivate
chondrocytes in three-dimensional cultures represents the
basis to ‘‘maintain’’ in vitro the original differentiated
active phenotype and its metabolic functions. This study
suggests that the combination of multiple ‘‘codes’’ (intensities,
wave forms and frequencies) generated by TAMMEF
system in 30 min enhances cell viability compared to ELF
with fixed frequency of 100 Hz, so we hypothesize that the
combination of codes may contain precise subsets of fre-
quencies and intensities and waveforms that positively
‘‘activate’’ chondrocytes. However, we do not know yet
what is the real positive subset because multiple codes
occur in a single application and it also depends on the
piece of music chosen [15–18]. Moreover, we hypothesize
that ELF system with fixed frequency of 100 Hz is unable
to positively activate chondrocytes such as TAMMEF
system but, as suggested by our results, ELF codes may
negatively interfere with chondrocytes. This negative
influence could explain the lowest viability recorded after
14 days of ELF treatments and also the highest percentage
of highly vacuolized cells in 3-D ELF alginate beads cul-
tures. Literature reported that during OA, chondrocytes are
eliminated such as by active caspase 3 (apoptosis) and by
cytoplasmic vacuolization (autophagy) [22, 23]. Further-
more, Roach et al. [24] introduced the term of
‘‘Chondroptosis’’ to design cell death type present in OA
cartilage which combines some apoptotic and some auto-
phagic processes. Together, these processes lead to com-
plete self-destruction of chondrocytes, as demonstrated by
the presence of empty lacunae. ELF treatments seem to
accelerate the second process involved in ‘‘Chondropto-
sis’’, that is the autophagy caused by cytoplasmic vacuo-
lization, as observed in both 2-D and 3-D ELF-treated
cultures. In addition, OA cartilage shows a multiplicity of
articular chondrocyte morphologies consisting in appar-
ently normal chondrocytes at the periphery and, through
degenerative matrix processes, in cellular loss and erosion
in the middle [33]. In the present study, the use of 3-D
alginate beads cultures mimics processes associated with
the initiation and progression of chondron remodeling, one
of the early events in the osteoarthritic process [34]. These
events of chondron remodeling consist in swelling and
remodeling of the pericellular microenvironment, initiation
of cell division and migration associated with the swollen
microenvironment, and continued proliferation and modi-
fied synthesis to form clonal (toward forming) chondrocyte
clusters [25, 35, 36]. Literature reports the identification of
four different types of clusters based on their morphology
and extracellular matrix composition [33, 37–39]. The first
type is composed of rounded cells in oval or round con-
formation. The second type is formed by concentric layers
of cells densely packed together. The third type is com-
posed by a layer of flattened interleaved cells around the
outside of the cluster with few cells in the middle. The final
cluster type consists of tightly packed cells, with membrane
boundaries difficult to discern. In the present study, we
recognize the four types of clusters with the lowest density
recorded for TAMMEF-treated cells (Fig. 4). However,
clustering formation represents an open debate in the lit-
erature since the exact steps leading to the formation of
these cell clusters have not been clearly identified [25].
Some authors reported that clustering phenomenon is the
final stage after cartilage softening, fibrillation and fissures
of human OA [34]. In the three-dimensional model
exposed in the present study, we cannot discern if the
clustering phenomenon is due exclusively to osteoarthritis
or it represents the normal evolution of articular chondro-
cytes because of the unavailability of healthy non-osteo-
arthritic cartilage and we acknowledge this limitation.
However, we could hypothesize that cluster formation is a
combination of the final stage of chondroptosis during OA
and cell proliferation in alginate bead lacunae.
In conclusion, the results shown in this work encourage
the use of electromagnetic fields in rheumatic diseases and
in particular the use of the innovative TAMMEF system in
OA treatments. Moreover, TAMMEF system could repre-
sent a valid non-pharmacological approach in the treatment
of this particular disease, especially because NSAIDs are
symptomatic drugs and they cannot be used for a long time.
The goal of every treatment for OA is not only to reduce
pain and stiffness, and to allow for greater movement, but
also to slow the progression of the disease. At present, it is
Fig. 6 3D cultured chondrocytes forming a cluster of type 2,
following Ross’ classification. Cells in more than one layer (arrow)
surround a cavity containing amorphous secreted material, nuclei
are euchromatic and cytoplasm is rich of multivesicular bodies
(o.m. 92,200)
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well known that NSAIDs are not able to restore cartilage
and that the therapeutic use of the so-called ‘‘Chondro-
protective’’ or ‘‘Structure-modifying’’ Agents is extremely
controversial. On the contrary, the analgesic activity of
electromagnetic fields is well documented in the literature,
and it is free of side effects and seems to be able to
interfere positively with cartilage metabolism. Further-
more, three-dimensional cultures represent a valid method
to study the possible consequences that electromagnetic
fields might have on OA chondrocytes because they mimic
closely the in vivo articular cartilage environment.
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